Variable | Overall (n = 62) | Men (n = 31) | Women (n = 31) | p value |
---|---|---|---|---|
Age (years) | 63.1 ± 5.2 | 63.5 ± 5.5 | 62.6 ± 4.9 | 0.473a |
Duration of diabetes (years) Ethnicity (white) | 11 (1–36) 50 (80.6%) | 12 (1–36) 28 (90.3%) | 10 (2–30) 22 (71%) | 0.493b 0.307a |
Weight (kg) | 82.1 ± 14.8 | 89.9 ± 13.8 | 74.2 ± 11.2 | < 0.001a |
Height (cm) | 164.8 ± 10.3 | 172.4 ± 7.6 | 157.2 ± 6.2 | < 0.001a |
BMI (kg/m2) | 30.1 ± 4.0 | 30.3 ± 3.8 | 30.0 ± 4.2 | 0.736a |
Fat-free mass (kg) | 35.2 ± 11.8 | 38.6 ± 12.1 | 31.7 ± 10.7 | 0.009a |
Fat mass (Kg) | 29.1 ± 8.8 | 27.9 ± 9.3 | 30.3 ± 8.3 | 0.278a |
Physical activity (steps/week) | 5522 (1496–18,097) | 5190 (1496–18,097) | 6011(1941–14,316) | 0.288a |
Hypertension | 62 (100%) | 31 (100%) | 31 (100%) | – |
Fasting plasma glucose (mg/dL) | 153.3 ± 46.2 | 162.9 ± 45.5 | 143.8 ± 45.6 | 0.105a |
A1C (%) | 7.6 (5.2–12.0) | 7.9 (5.9–12.0) | 7.2 (5.2–9.2) | 0.126b |
Total cholesterol (mg/dL) | 162.5 ± 40.3 | 158.0 ± 44.4 | 171.1 ± 33.7 | 0.197b |
HDL cholesterol (mg/dL) | 44.7 ± 13.8 | 39.8 ± 8.7 | 52.7 ± 13.8 | < 0.001b |
Triglycerides (mg/dL) | 172 (49–681) | 183 (49–681) | 157 (68–342) | 0.789b |
Medications | ||||
 Oral antihyperglycemic agents | 62 (100%) | 31 (100%) | 31 (100%) | – |
 Antihypertensive agents | 62 (100%) | 31 (100%) | 31 (100%) | – |
 Hypolipidemic agents | 42 (67.7%) | 22 (71%) | 20 (64.5%) | 0.587c |